LONDON, UNITED KINGDOM--(Marketwire - April 10, 2008) - NextGen Bioscience, Inc. (“NextGen”) (PINK SHEETS: NXGB), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced that Professor William H. Stimson of Scotland is joining its International Scientific Advisory Board.
